Search - Prime Therapeutics
-
Perspectives High-Cost Therapy Profile: March Detailed information about Sotatercept Subcutaneous (SC) High Cost Therapy Profile Cardiovascular Sotatercept Subcutaneous (SC) Merck/Bristol-Myers...
-
Breadcrumb Home Read, watch, listen Read Explore what's trending at Prime Example Link Example Link Card Title example Example Link Example Link Card Title example The Latest Tab 1 Press Releases...
-
Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs
Prime Article: Stories -
PUBLICATIONS FDA Decisions Expected: December 2025 Your monthly synopsis of new drugs expected to hit the market November 18, 2025 Drug pipeline for December 2025 At Prime Therapeutics (Prime), we...